A-shares, all in the green! Gold stocks, surge!

April 8, China’s A-share three major indexes opened higher across the board. The STAR Market 50 Index rose nearly 4%.

On the trading board, sectors such as non-ferrous metals, semiconductors, communication equipment, and components saw leading gains; meanwhile, sectors including oil, coal, diversified financials, and gas supply and heating saw the biggest declines.

Gold stocks surge

At the open, gold and precious metals concept stocks moved higher across the board, and gold stocks surged. Western Gold sealed its daily limit, and many other stocks—including Shanjin International, Hunan Gold, Zijin Mining, Zhaojin Gold, Sichuan Gold, and others—rose by more than 5%. According to the news, earlier this morning, gold and silver prices jumped; spot gold briefly stood above 4,850 USD/oz and gained more than 3% for the day.

The oil and gas sector opened sharply lower. Stocks such as Zhunyou Shares and Beiken Energy hit limit-downs in a one-line drop; Potential Hengxin, Keli Shares, Tongyuan Petroleum, Shouhua Gas, and others also fell.

According to the news, with both sides of Iran and the U.S. mediated by Pakistan, they reached a two-week temporary ceasefire agreement, which triggered a major plunge in international crude oil futures. In early trading, WTI crude oil futures briefly fell by nearly 17%.

The CPO concept was active. Mingpu Optics and Dongshan Precision both hit daily limit-ups; and stocks such as Changxin Borui, InnoSilicon? (中际旭创), Huilv Ecology, Deko Li, and Changguang Huaxin were among the top gainers.

A securities firm research report said that, driven by industry leaders and others, CPO is accelerating commercialization. The industry is innovating with various technical routes such as LPO, NPO, and XPO. CPO is currently in the early stage of industrial acceleration. Over the next three years is the core observation window for the CPO industry’s penetration rate to rise rapidly and for the supply-chain structure and value allocation across the industrial chain to be gradually formed.

Innovative drug concept stays active

The innovative drug concept remained active again and again. Nanjing Pharmaceuticals notched two consecutive daily limit-ups; Baihua Medical and Wanze Shares both sealed daily limit-ups; and Celgen Bio, Junshi Biosciences, Yinnuo (益诺思), Sunshine Nano? (阳光诺和), and others followed higher.

According to the news, on April 7, Beijing Municipal Medical Insurance Bureau and nine other departments jointly released the 《Several Measures by Beijing to Support the High-Quality Development of Innovative Medicine (2026)》, introducing 32 new initiatives.

Tianjin Pharmaceutical? (津药药业) was up and briefly hit a limit-up during the day, achieving an 8-day consecutive limit-up run. After that, the stock price declined; as of the time of this release, the gain narrowed to 1.3%.

On April 7, Tianjin Pharmaceutical? (津药药业) announced that within 10 consecutive trading days—between March 24, 2026 and April 7, 2026—the cumulative daily closing price gain deviation value reached 100%. Under the relevant provisions of the 《Trading Rules of the Shanghai Stock Exchange》, this falls under a situation of serious abnormal price fluctuations in stock trading.

Tianjin Pharmaceutical? (津药药业) said that the company has noticed that the market has labeled the company as an innovative drug concept stock and is engaging in speculation. The company’s current R&D is mainly focused on generic drugs, with no innovative drug projects under development. The related speculation appears to be based on a clear misunderstanding. The company’s main business is the R&D, production, and sales of steroid hormone APIs and amino acid APIs and their formulations. Meanwhile, the company has also noted market discussions about the pricing of hormone API products. Currently, the price of its steroid hormone APIs is generally stable, which has no impact on the company’s operating performance.

Hong Kong stocks: Zhipu soars

Hong Kong AI large-model and AI application sectors opened higher across the board. Zhipu rose by nearly 17% at one point during the trading session, and the latest gain was 13.09%.

A securities firm research report said that the commercialization progress of AI large models has achieved a “transformation from 1 to 10” quality shift. With domestic leading model manufacturers represented by Zhipu and MiniMax, paid Token consumption and ARR are showing an exponential leap.

Hong Kong stocks related to storage strengthened. As of this release, Lontime Technology? (澜起科技) rose by more than 7%, and Zhaoyi Innovation? (兆易创新) rose by more than 3%.

In terms of news, in the first quarter of 2026, DRAM contract prices rose 90% to 95% quarter-on-quarter. The price hikes in the second quarter have already been locked in in advance, with another increase of about 30%. TrendForce’s latest data shows that in the second quarter, the overall DRAM contract price will still rise 58% to 63% quarter-on-quarter, and the NAND Flash contract price will rise 70% to 75% quarter-on-quarter.

Proofread by: Gao Yuan